Michael Landsittel, Chief Financial Officer at Blueprint Medicines Corp (BPMC), sold 400 shares at $51.97 ($21K) on 2020-03-09, disclosed to the SEC on 2020-03-11.
Open-market sale of $21k BPMC by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BPMC | SELL | 2024-05-17 | $824K | — | Filing → |
| BPMC | SELL | 2024-05-06 | $1.1M | — | Filing → |
| BPMC | SELL | 2024-04-01 | $475K | — | Filing → |